Dual effect of digitalis glycosides on norepinephrine release from human atrial tissue and bovine adrenal chromaffin cells: Differential dependence on [Na+](i) and [Ca2+](i)

被引:11
作者
Haass, M
Serf, C
Gerber, SH
Kruger, C
Haunstetter, A
Vahl, CF
Nobiling, R
Kubler, W
机构
[1] UNIV HEIDELBERG, DEPT CARDIOTHORAC SURG, D-69115 HEIDELBERG, GERMANY
[2] UNIV HEIDELBERG, INST EXPT SURG, D-69115 HEIDELBERG, GERMANY
关键词
exocytosis; intracellular calcium concentration [Ca2+](i); intracellular sodium concentration [Na+](i); Na+/K+-ATPase; microfluorimetry; nicotine; non-exocytotic release mechanism; norepinephrine; ouabain;
D O I
10.1006/jmcc.1997.0398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It was the aim of the present study (1) to characterize the influence of Na+/K+-ATPase inhibition by the digitalis glycoside ouabain on both spontaneous and nicotine-evoked norepinephrine release from the human heart: and (2) to further investigate the role of glycoside-induced changes in [Na+](i) and [Ca2+](i) (determined by microfluorimetry) for catecholamine release. The latter experiments were performed in bovine adrenal medullary chromaffin cells (BCC), an established cell culture model for sympathetic nerves. Ouabain (1-1000 mu mol/l) exerted a dual effect on norepinephrine release (determined by HPLC) from incubated human atrial tissue: (I) Ouabain induced a concentration-dependent increase in norepinephrine release, that was calcium-independent and almost completely prevented by blockade of the uptake(1)-carrier by desipramine (1 mu mol/l). The characteristics of this release process are consistent with a non-exocytotic mechanism. (II) In addition, ouabain augmented the nicotine-evoked (1-100 mu mol/l) calcium-dependent norepinephrine release, which can be considered to be exocytotic. Na+/K+-ATPase inhibition also reduced the threshold concentration of nicotine from 10 to 1 mu mol/l and it delayed the rapid tachyphylaxis of its norepinephrine releasing effect in human atrial tissue. In BCC, ouabain increased [Na+](i), [Ca2+](i) and [H-3]-norepinephrine release in parallel. Under calcium-free conditions, not only the ouabain-induced increase in [Na+](i), but also [H-3]-norepinephrine release were enhanced. The ouabain-induced [H-3]-norepinephrine release was always closely related to changes in [Na+](i), indicating a key role of [Na+](i) for this calcium-independent non-exocytotic norepinephrine release. In addition, pretreatment with ouabain (1 mmol/l) augmented the nicotine-evoked (0.1-10 mu mol/l) increments in [Na+](i), [Ca2+](i) and [H-3]-norepinephrine release. As nicotine-induced norepinephrine release depends on an increase in both [Na+](i) and [Ca2+](i), these findings are indicative of an ouabain-mediated facilitation of exocytosis. In conclusion, increasing [Na+](i) and [Ca2+](i) inhibition of Na+/K+-aTPase by ouabain triggers non-exocytotic norepinephrine release, and facilitates nicotine-evoked exocytotic norepinephrine release. (C) 1997 Academic Press Limited.
引用
收藏
页码:1615 / 1627
页数:13
相关论文
共 46 条
[1]  
AKERA T, 1969, J PHARMACOL EXP THER, V170, P17
[2]   ISOLATED BOVINE ADRENOMEDULLARY CHROMAFFIN CELL - MODEL OF NEURONAL EXCITATION-SECRETION [J].
BROOKS, JC .
ENDOCRINOLOGY, 1977, 101 (05) :1369-1378
[3]   CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE [J].
CHIDSEY, CA ;
BRAUNWALD, E ;
MORROW, AG .
AMERICAN JOURNAL OF MEDICINE, 1965, 39 (03) :442-+
[4]   HORMONAL-REGULATION OF THE NA+-K+-ATPASE - MECHANISMS UNDERLYING RAPID AND SUSTAINED CHANGES IN PUMP ACTIVITY [J].
EWART, HS ;
KLIP, A .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (02) :C295-C311
[5]  
FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463
[6]   RELEASE OF NORADRENALINE FROM CAT SPLEEN BY SODIUM DEPRIVATION [J].
GARCIA, AG ;
KIRPEKAR, SM .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (04) :729-747
[7]   ROLE OF [NA+](I) AND [CA2+](I) IN NICOTINE-INDUCED NOREPINEPHRINE RELEASE FROM BOVINE ADRENAL CHROMAFFIN CELLS [J].
GERBER, SH ;
HAUNSTETTER, A ;
KRUGER, C ;
KAUFMANN, A ;
NOBILING, R ;
HAASS, M .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (03) :C572-C581
[8]   DIGOXIN - A NEUROHORMONAL MODULATOR IN HEART-FAILURE [J].
GHEORGHIADE, M ;
FERGUSON, D .
CIRCULATION, 1991, 84 (05) :2181-2186
[9]  
GILLIS RA, 1979, PHARMACOL REV, V31, P19
[10]  
GRAEFE KH, 1989, ADRENERGIC SYSTEM VE, P44